Next Article in Journal
The Molecular Detection of Germline Mutations in the BRCA1 and BRCA2 Genes Associated with Breast and Ovarian Cancer in a Romanian Cohort of 616 Patients
Next Article in Special Issue
Genomic Evolution Strategy in SARS-CoV-2 Lineage B: Coevolution of Cis Elements
Previous Article in Journal
Proteogenomics in Nephrology: A New Frontier in Nephrological Research
Previous Article in Special Issue
ADAR Family Proteins: A Structural Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

In Silico Analysis of Protein–Protein Interactions of Putative Endoplasmic Reticulum Metallopeptidase 1 in Schizosaccharomyces pombe

by
Dalia González-Esparragoza
1,2,
Alan Carrasco-Carballo
2,3,*,
Nora H. Rosas-Murrieta
1,
Lourdes Millán-Pérez Peña
1,
Felix Luna
4 and
Irma Herrera-Camacho
1,*
1
Laboratorio de Bioquímica y Biología Molecular, Centro de Química del Instituto de Ciencias (ICUAP), Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico
2
Laboratorio de Elucidación y Síntesis en Química Orgánica, Instituto de Ciencias de la Universidad Autónoma de Puebla (ICUAP), Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico
3
Consejo Nacional de Humanidades Ciencia y Tecnología, Instituto de Ciencias de la Universidad Autónoma de Puebla (ICUAP), Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico
4
Laboratorio de Neuroendocrinología, Facultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico
*
Authors to whom correspondence should be addressed.
Curr. Issues Mol. Biol. 2024, 46(5), 4609-4629; https://doi.org/10.3390/cimb46050280
Submission received: 28 February 2024 / Revised: 26 April 2024 / Accepted: 7 May 2024 / Published: 12 May 2024
(This article belongs to the Special Issue Structure and Function of Proteins: From Bioinformatics Insights)

Abstract

:
Ermp1 is a putative metalloprotease from Schizosaccharomyces pombe and a member of the Fxna peptidases. Although their function is unknown, orthologous proteins from rats and humans have been associated with the maturation of ovarian follicles and increased ER stress. This study focuses on proposing the first prediction of PPI by comparison of the interologues between humans and yeasts, as well as the molecular docking and dynamics of the M28 domain of Ermp1 with possible target proteins. As results, 45 proteins are proposed that could interact with the metalloprotease. Most of these proteins are related to the transport of Ca2+ and the metabolism of amino acids and proteins. Docking and molecular dynamics suggest that the M28 domain of Ermp1 could hydrolyze leucine and methionine residues of Amk2, Ypt5 and Pex12. These results could support future experimental investigations of other Fxna peptidases, such as human ERMP1.

1. Introduction

Endoplasmic Reticulum Metalloprotease 1 (ERMP1), also referred to as Fxna peptidase or Felix-ina, is a nine-transmembrane domain protease and a member of the M28 family of zinc metallopeptidases [1,2]. The gene was first discovered in the granulosa cells of rat ovarian follicles, where its expression is necessary for follicular organization, possibly to aid in the processing of protein precursors required for intraovarian cellular communication [2].
In vitro studies have suggested that overexpression of ERMP1 may contribute to increased endoplasmic reticulum (ER) stress by activating the Unfolded Protein Response (UPR) through GRP78-PERK-CHOP [1,3,4,5]. The role of the ERMP1 protein in cancer proliferation and progression through the PI3K/AKT/mTOR/β-catenin signaling pathways has been identified as a promising therapeutic strategy for treating various types of cancer [6,7]. Although there is evidence that ERMP1 could play an important role in these signaling pathways, the molecular mechanism remains unclear.
The use of Protein–Protein Interaction (PPI) networks has been instrumental in analyzing the molecular machinery of cells [8,9]. This approach is primarily employed to assign functional roles to potential proteins and to characterize multi-protein complexes and signaling pathways [10]. High-throughput technologies are available for the detection of PPIs, including yeast two-hybrid, immunoprecipitation, X-ray crystallography, and protein chips [11,12]. However, these techniques are limited to the analysis of reduced proteome coverage due to the time and cost required to perform experiments in the laboratory. Consequently, these limitations have prompted the development of computational tools for predicting large-scale PPIs, such as STRING, PEPPI, and deep neural networks [13,14,15]. Even so, the accuracy and reliability of these tools are highly dependent on the prior knowledge of the analyzed proteins. In contrast, there are databases that compile the interactions reported in publications based on experimental evidence, such as BIND, DIP, INTACT, MINT, and BioGRID [11,16,17,18,19,20].
In addition to the empirical discovery of PPIs, the comparative strategy of protein interactions conserved across species (interologues) has contributed to the functional annotation of uncharacterized proteins [21]. Although the prediction of human interologues inferred from model organisms is less frequent than expected, the high conservation of small groups of orthologues could be related to highly evolutionarily conserved cellular processes [9,21,22,23].
In particular, Schizosaccharomyces pombe is a fission yeast that shares many characteristics with eukaryotic cells, despite their evolutionary divergence of approximately 1144 million years [24]. Genetic conservation between S. pombe and humans has been confirmed by functional complementation of yeast mutants with human genes, showing high similarity between the two species [24,25,26,27]. Therefore, this model organism has been useful for the functional analysis of eukaryotic genes related to the cell cycle and the regulation of gene expression. In recent years, S. pombe has also been useful for the study of biochemical aspects of genetic products, such as the identification of domains related to catalytic activity and interactions with other proteins [28,29,30,31].
The orthologous gene erm1 (SPCC1259.02c) in S. pombe encodes the protein Ermp1 (Putative Endoplasmic Reticulum Metallopeptidase 1), which has not yet been fully characterized. According to homology, it can be inferred that Ermp1 may be involved in proteolysis, as it contains the M28 domain commonly found in zinc metallopeptidases.
As the UPR signaling pathway is conserved in S. pombe [32,33,34], it is possible to study ER stress and its relationship with Ermp1. Since there is no experimental evidence of the cellular process in which it participates and its possible target proteins are not known, in the present study, an in silico prediction of the PPI using a comparison of the interologues between humans and yeasts, as well as the molecular docking and dynamics of the M28 domain of Ermp1 with fission yeast proteins.

2. Materials and Methods

2.1. Prediction of Protein–Protein Interaction

The bioinformatics assays were carried out in Laboratorio de Bioquímica y Biología Molecular and Laboratorio de Elucidación y Síntesis en Química Orgánica of the BUAP, Puebla, Mexico. The period of all online software was carried out in January to February 2024. The PPI network of human ERMP1 was obtained from the BioGRID 4.4 repository [20]. The queries were conducted on the platform between 2020 and 2023, taking into account the latest updates to the database. The DIOPT Ortholog Finder server 9.0, Boston, MA, USA [35] was used to search for orthologous proteins in S. pombe using the PPI network of human ERMP1 as a reference. DIOPT employs a suite of tools and algorithms, including Ensembl Compara v104, HomoloGene v68, Inparanoid v8, Isobase v2, OMA, orthoMCL v6.6, Phylome v4, RoundUp, and TreeFam v9, to predict orthologs across a range of species, including humans, mice, flies, worms, zebrafish, and yeasts [35]. These tools provide a simplified method for integrating, comparing, and accessing orthological predictions based on sequence homology, phylogenetic trees, and functional similarity. Additionally, DIOPT calculates a simple score indicating the number of tools supporting a given orthologous gene pair relationship. Moreover, Gene Ontology was used to assign the subcellular localization and related biological processes. A PPI network for the Ermp1 protein was constructed using orthologous proteins identified in S. pombe. The orthologous relationship score assigned by DIOPT was used as a distribution criterion. The PPI network was then edited using Cytoscape 3.10.

2.2. In Silico Prediction of Cleavage Sequences of Proteolytic Candidates

In order to identify potential proteolytic candidates for interaction analysis with the M28 proteolytic domain of Ermp1, we considered proteins with DIOPT scores greater than 9 [35] and located in the cytosolic compartment, as well as membrane proteins with cytosolic regions. The proteins selected were the first to be identified as true human homologs in S. pombe when the BioGRID repository was reviewed. To predict the cleavage sequences for the metalloprotease family, the amino acid sequences of each protein were analyzed using PROSPER, Victoria, Australia [36]. The results were selected according to a cleavage probability score greater than 0.8 [37] for the subsequent protein–protein docking analysis.

2.3. Three-Dimensional Modeling of the M28 Domain of Ermp1 and Proteolytic Candidates

The M28 domain of Ermp1 and the target proteins Ypt5, Pex12, Oca8, Fis1 and Pmc1 were modeled by homology in Phyre2 v2.0, London, UK [38]. The templates were selected based on the percentage of homology of the sequences, domain conservation, and cellular function. Additionally, validation reports of potential templates in the Protein Data Bank were reviewed to select those that met the acceptance criteria, such as the experimental method, structure resolution, and percentile scores (ranging from 0 to 100) of global validation metrics like R-value free, R-value work, R-value observed, and Ramachandran outliers. The models were validated using PDBeFold v2.59 [39] and the PROCHECK-SAVES v6.0 Structure Validation Server, Europe Union [40]. A Q-score of approximately 1 and an RMSD value < 1 Å were considered the main modeling validation parameters due to their association with the percentage of aligned residues and the quality of the alignment of the secondary structures with respect to the template [39,41,42]. Furthermore, it has been confirmed that the cleavage sequences predicted in PROSPER were present in the 3D models of the proteolytic candidates, which were subsequently utilized for the docking analysis. As the N-terminal segment of the protein could not be modeled by homology and was essential for the docking analysis, the 3D model of Amk2 was obtained from the AlphaFold Protein Structure Database 4.0, Europe Union [43]. The model was subjected to a validation analysis using PROCHECK-SAVES v6.0, with the confidence score pLDDT of AlphaFold (ranging from 0 to 100) serving as the criterion for assessment.

2.4. Analysis of the Sequence and Structure of the M28 Domain of Ermp1

A sequence alignment was conducted using NCBI-BLAST to determine the percentage of homology between the human ERMP1 (Q7Z2K6) and Ermp1 from the S. pombe (O94702) proteins. The M28 domain of both proteases was subjected to analysis, with supplementary information retrieved from the PhosphositePlus v6.7.3 database regarding the post-translational modifications of ERMP1 in humans [44]. Furthermore, a predictive analysis of the serine phosphorylation sites of both proteases was carried out on the NetPhos 3.1, Lyngby, Denmark [45], with results scoring > 0.9 considered to be measures of the prediction accuracy [46].

2.5. Optimizing the Conformational Stability of Proteins through Energy Minimization Techniques

The PDB files were prepared, and the energy was minimized at pH 7.4 using the Protein Preparation Wizard (PrepWizard) tool from Maestro 13.0, New York, NY, USA [47] before the molecular docking. The integrity of each of the structures was reviewed and adjusted. Hydrogen atoms were added for each protein and the conformations of the rotamers of the polar residues were verified. Furthermore, the protonation and tautomeric states of Asp, Glu, Arg, Lys, and His were adjusted to pH 7.4. Additionally, the orientation of the hydrogen bonds was adjusted using PROPKA at pH 7.4 and the proteins were minimized using the OPLS4 force field with an RMDS of 0.3 Å [48]. The models were edited and visualized using UCSF Chimera 1.17.1, San Francisco, CA, USA [49] and Maestro 13.0.

2.6. Protein–Protein Docking of Ermp1 and Proteolytic Candidates

The Blind Docking process was conducted on the ClusPro 2.0 Boston, MA, USA [50] and using BioLuminate 4.5 software New York, NY, USA [51] in accordance with previously established parameters for the protein–protein docking of zinc metalloproteases [52]. The M28 domain of Ermp1 was designated as the rigid receptor, while the target proteins were considered to be the ligands. The PDB files were imported into ClusPro 2.0, and protein–protein docking was initiated automatically with an RMSD of less than 10 Å between the receptor and the ligand. The most promising interaction models were selected from the balanced energy category, as this is the recommended approach for the analysis of enzyme complexes. The score calculated by the program using the PIPER algorithm was derived from the favored energy contributions (electrostatics-favored, hydro-phobic-favored, and van der Waals-electrostatics), and thus, it was not considered a measure of binding affinity. Because ClusPro 2.0 removes metal ions during the processing of PDB files, Zn2+ ions from the M28 domain of Ermp1 were added to the interaction complexes according to the model coordinates. In the BioLuminate 4.5 software, the protein–protein docking runs were conducted with a limit of 70,000 rotations for each ligand evaluated. The electrostatic potential of the Zn2+ atoms of the M28 domain of Ermp1 was assigned for each inter-action complex using PIPER and Prime. The TOP30 ranking of the results obtained from each program was analyzed to search for interactions between the catalytic cavity of Ermp1 and the cleavage sequences of the proteolytic candidates that were predicted in PROSPER. The molecular interactions were analyzed using DIMPLOT tool of the software LigPlus v.2.2, Europe Union [53].

2.7. Solvation of Interaction Models in WaterMap

The Ermp1 interaction complexes were hydrated in the WaterMap tool, New York, NY, USA [54]. A molecular dynamics simulation was carried out in the presence of the solvent and a thermodynamic analysis of the water in the protein binding site was also performed [52,55]. The WaterMap calculations were run with the default simulation parameters: TIP4P solvent model at 300 K, 1 atmospheric pressure, and 2 ns simulation time. Subsequently, a cluster analysis was conducted to identify the principal hydration sites through the partitioning of the solvent density distribution within the binding cavity [54,56].

2.8. Molecular Dynamics Simulation

Molecular dynamics studies were conducted in Desmond, New York, NY, USA [57,58] to assess the stability of the interaction complexes: Ermp1–Pex12, Ermp1–Amk2 and Ermp1–Ypt5. The simulation was conducted within an orthorhombic box, with the ligand–protein complex situated in the center at a distance of 10 Å. Molecules of water were utilized to solvate the box, with a concentration of 150 nM of sodium chloride employed to simulate physiological conditions. The energy system was minimized using the OPLS4 force field with 2000 interactions, with a convergence criterion of 1 kcal/mol/Å [59]. Finally, a 120 ns simulation was conducted at 300 K and 1 bar of pressure. The root means square deviation (RMSD) and root mean square fluctuation (RMSF) were reported.

3. Results

3.1. Prediction of Protein–Protein Interactions of Ermp1 in S. pombe

BioGRID is an open-access database resource that hosts gene and protein interactions from multiple species, including yeasts, worms, flies, and humans. All the content is selected from experimental evidence reported in scientific publications, making it the most comprehensive repository of its kind [20]. Approximately 1.93 million of the reported interactions can be used to build interaction networks that facilitate biomedical research, particularly in the context of human health and diseases [20]. The BioGRID database currently contains a register of an interactome consisting of 19,229 interactions between 3844 proteins encoded in the yeast genome. Furthermore, it has been observed that at least 1355 proteins in the S. pombe proteome correspond to human orthologs that are related to diseases such as diabetes, hypertension, and cancer [27,29].
For example, the molecular study of S. pombe has proven invaluable for the functional analysis of genes related to human diseases, such as RAD1, RAD9, and HUS1. These human genes play a crucial role in the checkpoint response to DNA damage, and their aberrant expression has been linked to various cancers, including prostate, breast, intestinal, thyroid, and gastric cancers. Notably, these genes exhibit high homology with rad1, rad9, and hus1 in S. pombe [60,61].
Between 2020 and 2023, BioGRID recorded 190 proteins with experimental evidence of interaction with ERMP1 in H. sapiens (Q7Z2K6), including 8 viral proteins from SARS-CoV-2 and 1 from SARS-CoV (Figure 1). Despite this, no evidence of interaction was observed with the major UPR pathway proteins, such as IRE1, PERK, ATF6 and GRP78. However, the network analysis revealed the presence of proteins that are related to the activation of the pathway in the ER in a non-canonical manner, such as TM9SF4 [62], IER3IP1 [63] and BSCL2 [64], although the exact mechanism of their involvement remains unclear.
According to BioGRID’s records, there are currently no known instances of Ermp1 PPI in S. pombe (O94702), but there are positive genetic interactions (GIs) with the amk2 and gsk3 genes. These interactions were identified in a synthetic genetic array (SGA) study of single and double mutants of genes related to the TORC1 (Rapamycin Complex) signaling pathway [65].
GIs can be classified as either negative (lethality) or positive (suppression). In the case of a negative GI, a double mutant exhibits a more severe phenotype than that observed in single mutants, indicating that the gene products function redundantly in parallel on a signaling pathway. In cases of positive GI, it appears that the phenotype of the double mutants is less severe than that observed in the single mutants. This may suggest that the gene products interact within the same signaling pathway [66,67,68].
Ermp1 is suggested to have a physical interaction with Amk2 and Gsk3, as there may be a synergy between the GI and PPI. As a result, these proteins were included in the PPI network. Furthermore, the corresponding orthologous proteins in humans, PRKAB1 and GSK3B, were added to the human ERMP1 interaction network (Figure 1, highlighted in orange). PRKAB1 serves as a subunit of the heterotrimeric AMPK complex, which acts as a scaffold for the assembly of the PRKAA1 and PRKAG1 subunits. The AMPK complex plays a role as a negative regulator of the UPR pathway [69]. Additionally, GSK3B, a kinase, has been associated with an increased apoptosis response during ER stress, although its influence on the signaling pathway is not yet fully understood [70].
Analysis in DIOPT identified 45 human orthologous proteins in S. pombe (Figure 1, highlighted in yellow and orange, Table S1). The proteins were distributed in an interaction network based on the score assigned by DIOPT (Figure 2). Proteins with scores greater than 9 (Figure 2, highlighted in green, and Table S1) are considered true homologs, with conserved topological characteristics and cellular functions between fission yeast and humans.
The proteins were classified based on their subcellular localization and biological processes using the GO categories. A total of 29 proteins were found to be abundantly located in the ER membrane, cell membrane, and cytosol, while the remaining proteins were categorized in other cellular compartments such as the nucleus, vacuole, mitochondria, peroxisome, and Golgi apparatus (Figure 3A, Table S1). Fifteen proteins have been classified under transmembrane transport based on the biological process. The primary function of these proteins is to transport ions, including but not limited to Ca2+, Cu2+, Zn2+, and H+. Additional details can be found in Figure 3B and Table S1.
Mammalian cells rely on the endoplasmic reticulum (ER) as the primary organelle for Ca2+ storage due to the high oxidant potential required for the activity of numerous enzymes responsible for folding, post-translational processing, and protein trafficking [71]. Similarly, in S. pombe, calcium-dependent ATPases such as Pmr1 and Pmc1 are re-sponsible for regulating Ca2+ homeostasis in both the ER and vacuole [72]. Both transporters were identified in the S. pombe PPI network, which suggests a relationship between Ermp1 and Ca2+ homeostasis. On the other hand, 9 proteins associated with lipid and peptide metabolism were identified (Figure 3B). As previously noted, the ER plays a crucial role in various cellular processes, such as protein synthesis, Ca2+ storage, detoxification of chemical compounds, lipid synthesis, and lipid membrane assembly [73]. It is possible that the interaction of Ermp1 with metabolic proteins is linked to the maintenance of lipid and protein homeostasis within the organelle.
Considering that Ermp1 is a transmembrane protein, it is likely to interact with proteins involved in protein insertion into the ER membrane and vesicular trafficking. Moreover, Ermp1 could be regulated at the mRNA and protein levels through transcriptional regulation, ubiquitination, and palmitoylation mechanisms (Figure 3B). The proteins that were classified in a reduced proportion in the biological processes, such as DNA repair, nuclear division, and mitochondrial fission, could potentially interact with Ermp1 in the ER before being directed to different cellular compartments.

3.2. Comparing the M28 Domain of Ermp1 between Humans and S. pombe

Fxna peptidases are classified as members of the M28 family of metalloproteases due to their conservation of the His-Xaa-Asp and Glu-Glu motifs [74,75]. This family includes representative members such as aminopeptidase Y from S. cerevisiae, aminopeptidase S from Streptomyces griseus, aminopeptidase IAP from E. coli, and aminopeptidase Ap1 from Vibrio proteolyticus. The metalloproteases in question are characterized by the presence of two Zn2+ ions in their active center. These ions are tetrahedrally coordinated with three amino acids (His, Asp, and Glu) and a water molecule. Additionally, an aspartate or glutamate is coordinated to both metal ions [74,76].
Since Fxna peptidases such as Ermp1 have not yet been assigned to a subfamily due to their putative status, their structural or enzymatic characterization is not referenced. Therefore, the M28 domain of human ERMP1 was compared to its orthologous pair in S. pombe based on a sequence alignment. Both proteins share 37% identity and retain the active center residues: His, Asp, and Glu, which bind to Zn2+. The residues Glu, His, and Tyr play important roles in the catalytic process (Figure 4, highlighted in orange, purple, and magenta, respectively).
According to experimental evidence provided by PhosphoSitePlus [77], it has been shown that the Ser326 residue of human ERMP1 is phosphorylated [78]. In light of this information, we decided to investigate whether Ermp1 from S. pombe could also contain this site. As shown in Figure 4, we aligned Ser326 with Ser279 of Ermp1 from S. pombe, which is located within a conserved consensus sequence (highlighted in cyan and gray, respectively). The sequences of the metalloproteases were analyzed using NetPhos 3.1 [45]. It was observed that one of the predicted potential phosphorylation sites matched the reference and alignment (Tables S2 and S3).
In addition, the analysis predicted the presence of a phosphorylation site for Ser212 of human ERMP1 and Ser168 of Ermp1 from S. pombe (Figure 4, highlighted in gray and cyan, respectively; Tables S2 and S3). The specific type of kinases that could target this type of metalloproteases is currently unknown. However, the PPI network proposed for Ermp1 in fission yeast includes the serine/threonine kinase Gsk3. It is worth noting that phosphorylation of Gsk3 substrates typically leads to their inactivation or degradation [79]. It is possible that under certain physiological conditions, Ermp1’s activity may be regulated by kinases, such as Gsk3, as part of the cellular metabolic and energetic modulation [80].
In the PPI network, Ubi2, a ubiquitin protein ligase, was identified. As a result, a search for ubiquitination consensus sequences for Ermp1 was also conducted. It is worth noting that, according to experimental reference in PhosphoSitePlus, the Lys356 residue of human ERMP1 can be ubiquitinated [81,82]. Furthermore, in the sequence analysis, the alignment of Lys356 with Lys309 of Ermp1 from S. pombe was observed (Figure 4, highlighted in green). It is possible that Ubi2 may be involved in the proteasomal degradation of Ermp1, as suggested by the predictions.

3.3. 3D Modeling of the M28 Domain of Ermp1 from S. pombe

To proceed with the analysis, it was necessary to obtain a three-dimensional structure of Ermp1. Unfortunately, there are no crystallographic structures of Fxna peptidases in the Protein Data Bank. Therefore, we opted for in silico modeling of the protein.
The AlphaFold artificial intelligence has been widely recognized for its ability to accurately predict complete 3D structures using a deep-learning neural network system [83]. However, the 3D model of Ermp1 (O94702) obtained from the AlphaFold database was found to be unsuitable for analyzing the M28 domain due to its conformation, which inhibits interaction with other proteins.
Due to the shortage of templates exhibiting high homology percentages, adequate modeling coverage, and validation metrics essential for generating the 3D model of the M28 domain of Ermp1 from S. pombe, the available templates were meticulously evaluated. The selection process prioritized templates that could yield validation parameters closely aligned with the ideal values of PDBeFold and PROCHECK. Consequently, the aminopeptidase Ap1 from V. proteolyticus (PDB ID: 1RTQ) was identified as the optimal template for homology modeling in Phyre2.
The modeled sequence covered positions 39–339, with an identity percentage of 20% with respect to the template. A model was obtained with a Q-score of 0.76 and an RMSD of 0.72 Å. These parameters were observed to have a correlation with the percentage of aligned residues and the quality of the alignment of secondary structures with respect to the template. Figure 5A displays the 3D structure of the M28 domain of Ermp1, which shows the typical topology of metalloproteases. The enzyme is composed of β-sheets surrounded by α-helices, and its active center is represented by the Zn2+-binding residues located in the turns, highlighted in orange.
To ensure good quality, it is recommended that a model include more than 85–90% of its residues in the favored regions for each modeled secondary structure (β-sheets, α-helices, and loops) on a Ramachandran plot [84]. The model obtained from the M28 domain of Ermp1 in Phyre2 represents 85.4% of the residues in the favored regions in the Ramachandran plot (Figure 5B), which can be considered an acceptable model for the purposes of this study.
Figure 6A displays the surface representation of the M28 domain of Ermp1, highlighting its globular conformation and the exposed active center available for interaction with the target proteins and peptides. The catalytic cavity of the protein, as shown in Figure 6A with orange, purple, and magenta highlights, is formed by several Zn2+-binding residues, including His161, Asp173, Glu208, Glu234, and His307, as well as Glu207 and Tyr306. This cavity restricts access to small peptides and secondary structures, such as protein loops. Figure 6B illustrates the amino acids that were identified in the catalytic cavity.
Based on the reference metalloprotease Ap1 from V. proteolyticus [85], Zn2+ is coordinated by Asp173, Glu208, and His307 to activate a molecule from H2O to OH-. Additionally, Glu207 plays a crucial role in accepting the proton, which is necessary to increase the polarity of the nucleophilic attack of Zn2+ on the peptide bond of the substrate. It is important to note that these findings are subject to further investigation and interpretation.
The additional Zn2+ ion coordinates with His161, Asp173, and Glu234 to lower the pKa of the H2O molecule, promoting greater specificity and stabilization of the catalytic reaction [86]. Furthermore, Tyr306 (highlighted in magenta in Figure 6A,B) plays a role in stabilizing the transition state of the substrate intermediate in the final catalysis step.
The hydrophobic amino acids corresponding to residues Leu210, Ala235, Ile277, and Leu278 (highlighted in yellow in Figure 6A,B) could potentially play a crucial role in maintaining the structural conformation of the catalytic cavity. Additionally, as shown in Figure 6A,B, there are potential phosphorylation sites located near the active center of Ermp1 (highlighted in cyan), specifically Ser168 and Ser279. It is possible that the proteolytic activity of the metalloprotease is regulated by some type of kinase.

3.4. Identification of Potential Proteolytic Cleavage Sequences and Generation of 3D Models

In the absence of methodological references for investigating protein–protein interactions involving zinc metalloproteases and target proteins, we conducted a prior study focusing on predicting consensus sequences with proteolytic susceptibility. This investigation utilized PROSPER in conjunction with molecular-docking tools such as ClusPro and BioLuminate, as previously reported [52]. The analysis aimed to identify consensus sequences of known proteins that can be cleaved by specific metalloproteases, for which there was experimental evidence of enzymatic interaction. The study showed that the tools used had a high predictive power. The results were similar to those of the published reports on the Metalloproteinase 8-Fibronectin 1 [87] and Metalloproteinase 12-Factor XII [88], which were used as validation controls.
Herein, the proteolytic analysis of selected proteins from the predicted Ermp1 PPI network was also performed. A comparative analysis was conducted between the cleavage segments of the proteins and their secondary structures, with a focus on the M28 domain of Ermp1. This domain has a narrow catalytic cavity, which affects the cleavage prediction. The consensus sequences were accepted for analysis if they were located in loops, as these structures have a greater probability of being cleaved. The PPI network proteins were selected for analysis based on the order of identification in the comparative analysis of human–yeast interologues since 2020. Table 1 displays the results of the proteolytic analysis of selected proteins from the Ermp1 PPI network, specifically the cleavage sequences predicted by PROSPER for the proteins Amk2, Ypt5, Pex12, Oca8, Fis1, and Pmc1. Metalloproteinase 9 was found to have the highest scores, with scores > 0.8. The majority of the proteolytic cleavages were found to be located at the N-amino terminus of the Met and Leu residues.
The predictions made in this study are consistent with the findings concerning other metalloproteases of the M28 family, such as the aminopeptidase Y from S. cerevisiae and the aminopeptidase Ap1 from V. proteolyticus. These proteases prefer cleaving the N-amino of Leu, but they are also capable of hydrolyzing the N-amino of Lys, Arg, Met, Val, and Ile [86,89]. Table 2 shows the templates that were used for the homology modeling of the proteolytic candidates in Phyre2, with the exception of Amk2.
From the list of templates returned by Phyre2, those that exhibited reliability per-centages approaching 100% were subjected to analysis. The reliability percentage calculated by Phyre2 considers the homology of the sequences between the template and the target; therefore, this percentage is distinct from the quality of the model. Moreover, due to the limited availability of templates with high levels of homology, models for some S. pombe proteins were selected based on their ability to achieve validation parameters that were as close as possible to the ideal values. All the models passed the validation and accuracy criteria, obtaining a Q-score > 0.7 and RMSD values < 1 Å. Additionally, in the Ramachandran plots, over 85% of the modeled residues of each protein were found in the favored regions for each secondary structure (please refer to Figure S1).
For molecular docking, the cleavable segments located in the loops were considered instead of the β-sheets and/or α-helices of the 3D models of the proteolytic candidates. This is because these regions are typically more accessible, flexible, and susceptible to proteolytic cleavage [95].
In contrast to other proteins, it is worth noting that the 3D model of Amk2 was obtained from AlphaFold (P78789). It is important to mention that the crystallographic structures of Amk2 from S. pombe are deposited in the Protein Data Bank (PDBs ID: 2OOX, 2OOY, 2QR1, 2QRC, 2QRD, and 2QRE); however, it should be noted that they do not include the cleavage sequence of interest. This is due to the fact that the sequence is situated in an area with a consistent structural transition between order and disorder, referred to as an intrinsically disordered region (IDR), which cannot be resolved through crystallography [96,97]. As a result, homology modeling was also deemed unsuitable for incorporating IDRs.
Although the Ramachandran plot of the AlphaFold model indicated that 81.1% of the residues were located in the most favored regions, this can be attributed to the presence of residues in the IDRs. As these regions are considered dynamic, they lack a defined secondary structure (see Figure S2). This is consistent with the pLDDT score < 50 calculated in AlphaFold for that region, which, according to the program, would correspond to an unstructured region.
In the past two decades, the existence and abundance of proteins with IDRs such as Amk2 have been demonstrated [96]. The discovery of these proteins challenged the classic concept that a well-defined structure is essential for a protein to perform its function. Currently, it is known that IDRs are functional, as they are considered dynamic structures that are usually at the connection points of interactions with other proteins, mainly in cell signaling pathways [97]. Consequently, AlphaFold has emerged as a valuable bioinformatics tool for the prediction and modeling of IDRs.

3.5. Protein–Protein Docking between the M28 Domain of Ermp1 and Proteolytic Candidates

To further evaluate the PROSPER proteolytic susceptibility prediction, a protein–protein rigid-docking analysis was conducted using the ClusPro 2.0 server and BioLuminate software. The M28 domain of Ermp1 was docked with each of the proteolytic candidates. Table 3 shows the blind-docking prediction results that were identified within the TOP30 of the ranking and the size of the clusters.
The scores obtained from ClusPro and BioLuminate were found to be similar, likely due to the use of the same prediction algorithm. However, it is important to note that these scores cannot be considered as measures of the binding affinity without the use of refinement methods for energy minimization. Additionally, while the docking programs did show interaction shifts of the cleavage sites (indicated by red arrows in Table 3), it is worth noting that these interactions were found within the cleavage consensus sequences predicted by PROSPER for each proteolytic candidate.
Figure 7A–F and Figure S3 display the cleavage sequences of the evaluated proteins. These sequences were located in flexible secondary structures, with the exception of Oca8 and Fis1, which were located in the short chains of the α-helices. It is worth noting that although proteolysis in α-helices is not common, the enzyme–substrate interaction may still occur because secondary structures in the solution are typically in a dynamic equilibrium that fluctuates between the α-helix and the loops [98,99].
The interaction complexes were identified near the N-amino terminus of the Leu, Met, and Arg residues of the target proteins (Figure 7A–F, Figure S3 and Figure S4). It appears that Ermp1 may prefer these amino acids, which are similar to those found in the Ap1 aminopeptidase of V. proteolyticus with respect to proteolysis.
During the simulation of the models in WaterMap, it was noted that hydration appeared to facilitate the interaction of H2O molecules with Zn2+ in the catalytic cavity of the M28 domain of Ermp1 (refer to Figure 7A–F).
In the hydration and water-exchange mechanism of Zn2+, the bond distance between Zn2+ and the oxygen of H2O ranges between 2.0 and 2.1 Å in the first coordination sphere of the metal, 3.6 Å in the second coordination sphere, and between 2.7 and 3.0 Å in the transition states between both spheres [100].
The distances between Zn2+ and water oxygen were measured in each of the docking models (see Figure S5). Variations in the length of the bonds were observed that ranged between 2.46 and 3.51 Å; therefore, the interactions would be found between the first and second coordination spheres of Zn2+. These results are consistent with other computational chemistry studies, where ligand exchange and catalytic mechanisms are favored in the transition states of both coordination spheres [101,102,103].
The results of the protein–protein docking procedure indicated that three systems were worthy of further investigation through molecular dynamics studies. The Ermp1–Amk2, Ermp1–ypt5, and Ermp1–Pex12 systems were selected based on the observation of highly interactive behavior between the catalytic cavity of the M28 domain of Ermp1 and the cleavage sequences present in the target proteins. The root mean square deviation (RMSD) of each snapshot relative to the initial energy-minimized structure was calculated following alignment based on the Cα atoms for each trajectory. As depicted in Figure 8, the RMSD values for all the systems exhibited reasonable fluctuations, ranging from 0.8 to 2.6 Å throughout the simulations. It can be noted that the interaction contacts of the complexes exhibit a constant behavior throughout the 120 ns simulation time.
The RMSF trajectory data revealed that the fluctuations among most amino acids ranged from 0.4 to 3.2 Å (see Figure S6). Notably, the initial residues displayed the most substantial variations, spanning from residue 39 to 100. These residues correspond to protein regions serving as loops, which grant greater flexibility of movement. In contrast, amino acids located within the catalytic region displayed lower flexibility. Consequently, their capacity to bind to the target proteins may be linked to the observed stability of interactions.

4. Discussion

This study presents the initial in silico predictions of the protein–protein interactions of the putative protein Ermp1 in S. pombe. Based on the results, it can be proposed that Ermp1 could play a role in maintaining the homeostasis of Ca2+, amino acids, and proteins in the endoplasmic reticulum, an organelle with high protein synthesis and degradation activity. The analysis of the M28 domain of Ermp1 was interesting because two phosphorylation sites near the active center were predicted. Therefore, it is hypothesized that the proteolytic activity of Ermp1 could depend on serine phosphorylation. The molecular docking suggests that Ermp1 could interact preferentially with consensus sequences located in the loops of the proteins Amk2, Ypt5 and Pex12 from the PPI predictions. These interactions suggest that Ermp1 could act as an aminopeptidase, particularly near the N-amino of the Leu and Met residues.
Aminopeptidases have been found to be present in intracellular organelles, cytoplasm, and cell membranes [104]. Their role in protein degradation is crucial, as they cleave peptides generated by the proteasome or hydrolyze free amino acids for recycling and new protein synthesis [105]. It is known that the proteasome releases peptides of 6–24 amino acids, which can be rapidly degraded by cytosolic peptidases [104,105].
For many years, aminopeptidases have been extensively studied in relation to various cellular processes and their implications in the development of different pathologies, such as inflammatory processes, diabetes, and cancer [106]. It has been observed that in cancer cells, the overexpression of aminopeptidases facilitates the exogenous supply of amino acids, which is necessary for their survival and proliferation [104,107]. In addition, it has been described that the tumor microenvironment increases the rate of protein synthesis, which in turn favors the increase in the expression of aminopeptidases [105,108,109].
In vitro studies have suggested that human ERMP1 increases the proliferation and invasion of cancer cells through the PIK3/AKT/mTOR/β-catenin pathway. However, the molecular mechanism is still unclear [4,5,6,7]. This study proposes a possible interaction of Ermp1 with Amk2 and Gsk3 in S. pombe. These two signaling proteins regulate the metabolic and transcriptional activity of cells through TOR-dependent processes in response to environmental signals [65,110,111,112,113]. In humans, orthologous proteins of Amk2 and Gsk3 (PRKAB1 and GSK3B, respectively) have been linked to the ER stress response through the modulation of the UPR pathway [114,115,116]. Furthermore, it would be interesting to explore whether there is a correlation between Ermp1 and both Amk2 and Gsk3 in S. pombe within signaling pathways such as TOR and UPR, which are highly conserved in mammals, including humans [117,118]. In humans, these pathways are modified in some types of cancer due to ERMP1 overexpression, but the mechanism is unknown. Therefore, study of the Ermp1 in S. pombe could help elucidate its function in human cells.
It is important to mention that the selection of appropriate 3D models is essential for molecular-docking analysis. However, currently it has not yet been possible to experimentally determine the three-dimensional structures of a large number of proteins from different organisms of biological interest. For this reason, the availability of suitable templates for homology modeling is usually limited. In this study, the Phyre2 and AlphaFold Protein Structure databases were employed to generate 3D models of the proteins of interest. Both tools are open access, facilitating exploration of bioinformatics analysis of different proteins with satisfactory results [119,120,121]. Nevertheless, the use of other, more powerful modeling tools should be considered for the validation of structural predictions.
Finally, ClusPro 2.0 and BioLuminate 4.5 are molecular-docking tools that have been widely utilized in diverse biological systems due to their automated computational system and the quality of the predictions, which exceed 50% of the success rate compared to other tools [122,123,124,125]. Since the predictions in both programs were similar, it can be suggested that they are congruent; however, other tools could be used to confirm the results.

5. Conclusions

This bioinformatics study proposes the first prediction of the PPIs of Ermp1 with 45 proteins in S. pombe, which are highly conserved in humans. According to the GO classification, this group of proteins is mostly related to the transport of calcium in the ER and the metabolism of amino acids and proteins. Therefore, it is very possible that Ermp1 is also related to these processes. The results of the molecular docking and dynamics of the M28 domain with Amk2, Ypt5 and Pex12 support the idea that Ermp1 could act as an aminopeptidase with a preference to hydrolyze the N-amino of leucine and methionine residues. It is important to remember that enzymatic assays are necessary to confirm these predictions. In conclusion, these results provide the basis for future experimental research, which will contribute to the elucidation of the cellular function of other Fxna peptidases, such as human Ermp1.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/cimb46050280/s1, Figure S1: Three-dimensional structures of target proteins of Ermp1 from S. pombe. Homology modeling in Phyre2 and Ramachandran plot. Model validation performed using the PROCHECK-SAVES v6.0 server. Editing of the model performed in UCSF Chimera 1.17.1; Figure S2: AlphaFold prediction and Ramachandran plot of the 3D structure of Amk2 from S. pombe; Figure S3: Molecular docking of the M28 domain of Ermp1 with protein targets. Ligand cleavage segment is shown in blue. Cleavage residues are shown in pink. Solvation performed in the WaterMap tool. Editing of the models performed in Maestro 13.0; Figure S4: DIMPLOT 2D-interaction plot of the M28 domain of Ermp1 with protein targets (A–F). The horizontal dashed line represents the interface. The green dotted line represents the hydrogen bond length, while the arc represents the hydrophobic interaction. The dotted boxes delineate the identified interactions between the residues of Ermp1’s catalytic cavity and the potential cleavage residues within the target proteins; Figure S5: Representation of the solvation of the interaction complexes of the M28 domain of Ermp1 and cleavage sites of protein targets. Binding sites of Zn2+ are shown in orange. Catalytic site is shown in purple. Catalytic stabilizer is shown in magenta. Cleavage residues are shown in pink. Solvation performed in the WaterMap tool. Editing of the models performed in Maestro 13.0; Figure S6: Analysis of the RMSF trajectories of residues of the protein–protein complexes. The root mean square fluctuation (RMSF) was calculated to examine the residual fluctuations throughout the simulation time for Ermp1–Amk2, Ermp1–Pex12, and Ermp1–Ypt5 (A–C, respectively). Each simulation was conducted for 120 ns in the Desmond Molecular Dynamics System to assess the stability of the protein–protein interaction; Table S1: Comparison of orthologous proteins that interact with ERMP1/Ermp1 in humans and S. pombe. GO cellular component, biological process annotation, DIOPT score, similarity, and identity percentages. Proteins highlighted in gray were selected for proteolytic propensity analysis and molecular docking; Table S2: Predictions of the phosphorylation sites in NetPhos 3.1 of human ERMP1; Table S3: Predictions of the phosphorylation sites in NetPhos 3.1 of Ermp1 from S. pombe.

Author Contributions

Conceptualization, D.G.-E., A.C.-C., I.H.-C., N.H.R.-M., L.M.-P.P. and F.L.; methodology, D.G.-E., A.C.-C. and I.H.-C.; software, A.C.-C.; validation, D.G.-E. and A.C.-C.; formal analysis, D.G.-E., A.C.-C. and I.H.-C.; investigation, D.G.-E. and I.H.-C.; resources, I.H.-C.; data curation, D.G.-E. and A.C.-C.; writing—original draft preparation, D.G.-E. and I.H.-C.; writing—review and editing, I.H.-C., A.C.-C., N.H.R.-M., L.M.-P.P. and F.L.; visualization, D.G.-E., A.C.-C. and I.H.-C.; supervision, I.H.-C., A.C.-C., N.H.R.-M., L.M.-P.P. and F.L.; project administration, I.H.-C.; funding acquisition, I.H.-C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by ICUAP and VIEP, funding number 100429633-VIEP 2021–2022 to Benemérita Universidad Autónoma de Puebla. Dalia González Esparragoza (BUAP ID: 220570034) received a scholarship from CONAHCYT-MEXICO (820490).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The authors confirm that the data supporting the findings of this study are available within the article.

Acknowledgments

We appreciated using the Schrödinger license supported by the CONAHCYT PRONACES Project 317580. We also appreciate the cost per publication (APC) support that was funded by ICUAP and VIEP.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Grandi, A.; Santi, A.; Campagnoli, S.; Parri, M.; De Camilli, E.; Song, C.; Jin, B.; Lacombe, A.; Castori-Eppenberger, S.; Sarmientos, P.; et al. ERMP1, a Novel Potential Oncogene Involved in UPR and Oxidative Stress Defense, Is Highly Expressed in Human Cancer. Oncotarget 2016, 7, 63596–63610. [Google Scholar] [CrossRef] [PubMed]
  2. Garcia-Rudaz, C.; Luna, F.; Tapia, V.; Kerr, B.; Colgin, L.; Galimi, F.; Dissen, G.A.; Rawlings, N.D.; Ojeda, S.R. Fxna, a Novel Gene Differentially Expressed in the Rat Ovary at the Time of Folliculogenesis, Is Required for Normal Ovarian Histogenesis. Development 2007, 134, 945–957. [Google Scholar] [CrossRef] [PubMed]
  3. Qu, J.; Zhang, L.; Li, L.; Su, Y. MiR-148b Functions as a Tumor Suppressor by Targeting Endoplasmic Reticulum Metallo Protease 1 in Human Endometrial Cancer Cells. Oncol. Res. 2018, 27, 81–88. [Google Scholar] [CrossRef] [PubMed]
  4. Chi, L.; Jiao, D.; Nan, G.; Yuan, H.; Shen, J.; Gao, Y. MiR-9-5p Attenuates Ischemic Stroke through Targeting ERMP1-Mediated Endoplasmic Reticulum Stress. Acta Histochem. 2019, 121, 151438. [Google Scholar] [CrossRef] [PubMed]
  5. Dastghaib, S.; Mokarram, P.; Erfani, M.; Ghavami, S.; Hosseini, S.V.; Zamani, M. Endoplasmic Reticulum Metallo Protease 1, a Triggering Factor for Unfolded Protein Response and Promising Target in Colorectal Cancer. Biologia 2021, 76, 2403–2411. [Google Scholar] [CrossRef]
  6. Lu, H.; Hu, J.; Li, J.; Lu, W.; Deng, X.; Wang, X. MiR-328-3p Overexpression Attenuates the Malignant Proliferation and Invasion of Liver Cancer via Targeting Endoplasmic Reticulum Metallo Protease 1 to Inhibit AKT Phosphorylation. Ann. Transl. Med. 2020, 8, 754. [Google Scholar] [CrossRef] [PubMed]
  7. Rahmani-Kukia, N.; Zamani, M.; Mokarram, P. ERMP1 Facilitates The Malignant Characteristics of Colorectal Cancer Cells through Modulating PI3K/AKT/β-Catenin Pathway and Localization of GRP78. Cell J. 2023, 25, 470–482. [Google Scholar] [CrossRef] [PubMed]
  8. Raman, K. Construction and Analysis of Protein—Protein Interaction Networks. Autom. Exp. 2010, 2, 2. [Google Scholar] [CrossRef] [PubMed]
  9. Zainal-Abidin, R.-A.; Afiqah-Alen, N.; Abdullah-Zawawi, M.-R.; Harun, S.; Mohamed-Hussein, Z.-A. Protein—Protein Interaction (PPI) Network of Zebrafish Oestrogen Receptors: A Bioinformatics Workflow. Life 2022, 12, 650. [Google Scholar] [CrossRef]
  10. de Las Rivas, J.; Fontanillo, C. Protein-Protein Interactions Essentials: Key Concepts to Building and Analyzing Interactome Networks. PLoS Comput. Biol. 2010, 6, e1000807. [Google Scholar] [CrossRef]
  11. Skrabanek, L.; Saini, H.K.; Bader, G.D.; Enright, A.J. Computational Prediction of Protein-Protein Interactions. Mol. Biotechnol. 2008, 38, 1–17. [Google Scholar] [CrossRef]
  12. Murakami, Y.; Tripathi, L.P.; Prathipati, P.; Mizuguchi, K. Network Analysis and in Silico Prediction of Protein–Protein Interactions with Applications in Drug Discovery. Curr. Opin. Struct. Biol. 2017, 44, 134–142. [Google Scholar] [CrossRef]
  13. Franceschini, A.; Szklarczyk, D.; Frankild, S.; Kuhn, M.; Simonovic, M.; Roth, A.; Lin, J.; Minguez, P.; Bork, P.; Von Mering, C.; et al. STRING v9.1: Protein-Protein Interaction Networks, with Increased Coverage and Integration. Nucleic Acids Res. 2013, 41, D808–D815. [Google Scholar] [CrossRef]
  14. Bell, E.W.; Schwartz, J.H.; Freddolino, P.L.; Zhang, Y. PEPPI: Whole-Proteome Protein-Protein Interaction Prediction through Structure and Sequence Similarity, Functional Association, and Machine Learning. J. Mol. Biol. 2022, 434, 167530. [Google Scholar] [CrossRef]
  15. Zhang, L.; Yu, G.; Xia, D.; Wang, J. Protein–Protein Interactions Prediction Based on Ensemble Deep Neural Networks. Neurocomputing 2019, 324, 10–19. [Google Scholar] [CrossRef]
  16. Bader, G.D.; Donaldson, I.; Wolting, C.; Ouellette, B.F.F.; Pawson, T.; Hogue, C.W. V BIND-The Biomolecular Interaction Network Database. Nucleic Acids Res. 2001, 29, 242–245. [Google Scholar] [CrossRef] [PubMed]
  17. Xenarios, I.; Salwínski, D.; Duan, J.; Higney, P.; Kim, S.-M.; Eisenberg, D. DIP, the Database of Interacting Proteins: A Research Tool for Studying Cellular Networks of Protein Interactions. Nucleic Acids Res. 2002, 30, 303–305. [Google Scholar] [CrossRef] [PubMed]
  18. del Toro, N.; Shrivastava, A.; Ragueneau, E.; Meldal, B.; Combe, C.; Barrera, E.; Perfetto, L.; How, K.; Ratan, P.; Shirodkar, G.; et al. The IntAct Database: Efficient Access to Fine-Grained Molecular Interaction Data. Nucleic Acids Res. 2022, 50, D648–D653. [Google Scholar] [CrossRef]
  19. Zanzoni, A.; Montecchi-Palazzi, L.; Quondam, M.; Ausiello, G.; Helmer-Citterich, M.; Cesareni, G. MINT: A Molecular INTeraction Database. FEBS Lett. 2002, 513, 135–140. [Google Scholar] [CrossRef]
  20. Oughtred, R.; Rust, J.; Chang, C.; Breitkreutz, B.J.; Stark, C.; Willems, A.; Boucher, L.; Leung, G.; Kolas, N.; Zhang, F.; et al. The BioGRID Database: A Comprehensive Biomedical Resource of Curated Protein, Genetic, and Chemical Interactions. Protein Sci. 2021, 30, 187–200. [Google Scholar] [CrossRef]
  21. Lee, S.A.; Chan, C.H.; Tsai, C.H.; Lai, J.M.; Wang, F.S.; Kao, C.Y.; Huang, C.Y.F. Ortholog-Based Protein-Protein Interaction Prediction and Its Application to Inter-Species Interactions. BMC Bioinform. 2008, 9, S11. [Google Scholar] [CrossRef] [PubMed]
  22. Breitkopf, S.B.; Yang, X.; Begley, M.J.; Kulkarni, M.; Chiu, Y.H.; Turke, A.B.; Lauriol, J.; Yuan, M.; Qi, J.; Engelman, J.A.; et al. A Cross-Species Study of PI3K Protein-Protein Interactions Reveals the Direct Interaction of P85 and SHP2. Sci. Rep. 2016, 6, 20471. [Google Scholar] [CrossRef] [PubMed]
  23. Wiles, A.M.; Doderer, M.; Ruan, J.; Gu, T.T.; Ravi, D.; Blackman, B.; Bishop, A.J.R. Building and Analyzing Protein Interactome Networks by Cross-Species Comparisons. BMC Syst. Biol. 2010, 4, 36. [Google Scholar] [CrossRef] [PubMed]
  24. Wood, V.; Gwilliam, R.; Rajandream, M.-A.; Lyne, M.; Lyne, R.; Stewart, A.; Sgouros, J.; Peat, N.; Hayles, J.; Baker, S.; et al. The Genome Sequence of Schizosaccharomyces Pombe. W. R. McCombie 2002, 415, 871–880. [Google Scholar] [CrossRef] [PubMed]
  25. Owen, N.; Doe, C.L.; Mellor, J.; Davies, K.E. Characterization of the Schizosaccharomyces Pombe Orthologue of the Human Survival Motor Neuron (SMN) Protein. Hum. Mol. Genet. 2000, 9, 675–684. [Google Scholar] [CrossRef] [PubMed]
  26. Zhao1, Y.; Lieberman, H.B. Schizosaccharomyces Pombe: A Model for Molecular Studies of Eukaryotic Genes. DNA Cell Biol. 1995, 14, 359–371. [Google Scholar] [CrossRef] [PubMed]
  27. Harris, M.A.; Rutherford, K.M.; Hayles, J.; Lock, A.; Bähler, J.; Oliver, S.G.; Mata, J.; Wood, V. Fission Stories: Using PomBase to Understand Schizosaccharomyces Pombe Biology. Genetics 2022, 220, iyab222. [Google Scholar] [CrossRef]
  28. Deshpande, G.P.; Hayles, J.; Hoe, K.L.; Kim, D.U.; Park, H.O.; Hartsuiker, E. Screening a Genome-Wide S. Pombe Deletion Library Identifies Novel Genes and Pathways Involved in Genome Stability Maintenance. DNA Repair 2009, 8, 672–679. [Google Scholar] [CrossRef] [PubMed]
  29. Vo, T.V.; Das, J.; Meyer, M.J.; Cordero, N.A.; Akturk, N.; Wei, X.; Fair, B.J.; Degatano, A.G.; Fragoza, R.; Liu, L.G.; et al. A Proteome-Wide Fission Yeast Interactome Reveals Network Evolution Principles from Yeasts to Human. Cell 2016, 164, 310–323. [Google Scholar] [CrossRef]
  30. Wang, Z. Big Data Mining Powers Fungal Research: Recent Advances in Fission Yeast Systems Biology Approaches. Curr. Genet. 2017, 63, 427–433. [Google Scholar] [CrossRef]
  31. Vyas, A.; Freitas, A.V.; Ralston, Z.A.; Tang, Z. Fission Yeast Schizosaccharomyces Pombe: A Unicellular “Micromammal” Model Organism. Curr. Protoc. 2021, 1, e151. [Google Scholar] [CrossRef] [PubMed]
  32. Guydosh, N.R.; Kimmig, P.; Walter, P.; Green, R. Regulated Ire1-Dependent MRNA Decay Requires No-Go MRNA Degradation to Maintain Endoplasmic Reticulum Homeostasis in S. Pombe. Elife 2017, 6, e29216. [Google Scholar] [CrossRef] [PubMed]
  33. Kimmig, P.; Diaz, M.; Zheng, J.; Williams, C.C.; Lang, A.; Aragón, T.; Li, H.; Walter, P. The Unfolded Protein Response in Fission Yeast Modulates Stability of Select MRNAs to Maintain Protein Homeostasis. Elife 2012, 2012, e00048. [Google Scholar] [CrossRef] [PubMed]
  34. Van Anken, E.; Pincus, D.; Coyle, S.; Aragón, T.; Osman, C.; Lari, F.; Gómez Puerta, S.; Korennykh, A.V.; Walter, P. Specificity in Endoplasmic Reticulum-Stress Signaling in Yeast Entails a Step-Wise Engagement of HAC1 MRNA to Clusters of the Stress Sensor Ire1. Elife 2014, 3, e05031. [Google Scholar] [CrossRef] [PubMed]
  35. Hu, Y.; Flockhart, I.; Vinayagam, A.; Bergwitz, C.; Berger, B.; Perrimon, N.; Mohr, S.E. An Integrative Approach to Ortholog Prediction for Disease-Focused and Other Functional Studies. BMC Bioinform. 2011, 12, 357. [Google Scholar] [CrossRef] [PubMed]
  36. Song, J.; Tan, H.; Perry, A.J.; Akutsu, T.; Webb, G.I.; Whisstock, J.C.; Pike, R.N. PROSPER: An Integrated Feature-Based Tool for Predicting Protease Substrate Cleavage Sites. PLoS ONE 2012, 7, e50300. [Google Scholar] [CrossRef] [PubMed]
  37. Song, J.; Li, F.; Leier, A.; Marquez-Lago, T.T.; Akutsu, T.; Haffari, G.; Chou, K.C.; Webb, G.I.; Pike, R.N. PROSPERous: High-Throughput Prediction of Substrate Cleavage Sites for 90 Proteases with Improved Accuracy. Bioinformatics 2018, 34, 684–687. [Google Scholar] [CrossRef]
  38. Kelley, L.A.; Mezulis, S.; Yates, C.M.; Wass, M.N.; Sternberg, M.J.E. The Phyre2 Web Portal for Protein Modeling, Prediction and Analysis. Nat. Protoc. 2015, 10, 845–858. [Google Scholar] [CrossRef]
  39. Krissinel, E.; Henrick, K. Secondary-Structure Matching (SSM), a New Tool for Fast Protein Structure Alignment in Three Dimensions. Acta Crystallogr. D Biol. Crystallogr. 2004, 60, 2256–2268. [Google Scholar] [CrossRef]
  40. Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J.M. Computer Programs PROCHECK: A Program to Check the Stereochemical Quality of Protein Structures. J. Appl. Crystallogr. 1993, 26, 283–291. [Google Scholar] [CrossRef]
  41. Julian, A.T.; Mascarenhas Dos Santos, A.C.; Pombert, J.F. 3DFI: A Pipeline to Infer Protein Function Using Structural Homology. Bioinform. Adv. 2021, 1, vbab030. [Google Scholar] [CrossRef]
  42. Read, R.J.; Adams, P.D.; Arendall, W.B.; Brunger, A.T.; Emsley, P.; Joosten, R.P.; Kleywegt, G.J.; Krissinel, E.B.; Lütteke, T.; Otwinowski, Z.; et al. A New Generation of Crystallographic Validation Tools for the Protein Data Bank. Structure 2011, 19, 1395–1412. [Google Scholar] [CrossRef] [PubMed]
  43. David, A.; Islam, S.; Tankhilevich, E.; Sternberg, M.J.E. The AlphaFold Database of Protein Structures: A Biologist’s Guide. J. Mol. Biol. 2022, 434, 167336. [Google Scholar] [CrossRef] [PubMed]
  44. Hornbeck, P.V.; Kornhauser, J.M.; Tkachev, S.; Zhang, B.; Skrzypek, E.; Murray, B.; Latham, V.; Sullivan, M. PhosphoSitePlus: A Comprehensive Resource for Investigating the Structure and Function of Experimentally Determined Post-Translational Modifications in Man and Mouse. Nucleic Acids Res. 2012, 40, D261–D270. [Google Scholar] [CrossRef] [PubMed]
  45. Blom, N.; Sicheritz-Pontén, T.; Gupta, R.; Gammeltoft, S.; Brunak, S. Prediction of Post-Translational Glycosylation and Phosphorylation of Proteins from the Amino Acid Sequence. Proteomics 2004, 4, 1633–1649. [Google Scholar] [CrossRef]
  46. Xu, Y.; Song, J.; Wilson, C.; Whisstock, J.C. PhosContext2vec: A Distributed Representation of Residue-Level Sequence Contexts and Its Application to General and Kinase-Specific Phosphorylation Site Prediction. Sci. Rep. 2018, 8, 8240. [Google Scholar] [CrossRef] [PubMed]
  47. Bhachoo, J.; Beuming, T. Investigating Protein–Peptide Interactions Using the Schrödinger Computational Suite. Methods Mol. Biol. 2017, 1561, 235–254. [Google Scholar] [CrossRef] [PubMed]
  48. Carrasco-Carballo, A.; Mendoza-Lara, D.F.; Rojas-Morales, J.A.; Alatriste, V.; Merino-Montiel, P.; Luna, F.; Sandoval-Ramirez, J. In Silico Study of Coumarins Derivatives with Potential Use in Systemic Diseases. Biointerface Res. Appl. Chem. 2023, 13, 240. [Google Scholar] [CrossRef]
  49. Pettersen, E.F.; Goddard, T.D.; Huang, C.C.; Couch, G.S.; Greenblatt, D.M.; Meng, E.C.; Ferrin, T.E. UCSF Chimera—A Visualization System for Exploratory Research and Analysis. J. Comput. Chem. 2004, 25, 1605–1612. [Google Scholar] [CrossRef]
  50. Kozakov, D.; Hall, D.R.; Xia, B.; Porter, K.A.; Padhorny, D.; Yueh, C.; Beglov, D.; Vajda, S. The ClusPro Web Server for Protein–Protein Docking. Nat. Protoc. 2017, 12, 255–278. [Google Scholar] [CrossRef]
  51. Schrödinger Release 2023-2b: BioLuminate; Schrödinger, LLC.: New York, NY, USA, 2021.
  52. González-Esparragoza, D.; Carrasco-Carballo, A.; Rosas-Murrieta, N.H.; Millán-Pérez-Peña, L.; Herrera-Camacho, I. In Silico Analysis for Metalloenzyme-Protein Interactions Applied to MMP8-Fibronectin 1 and MMP12-Factor XII. Life Silico 2023, 1, 26–33. [Google Scholar]
  53. Laskowski, R.A.; Swindells, M.B. LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery. J. Chem. Inf. Model. 2011, 51, 2778–2786. [Google Scholar] [CrossRef]
  54. Schrödinger Release 2023-2b: WaterMap; Schrödinger, LLC.: New York, NY, USA, 2021.
  55. Biswal, J.; Jayaprakash, P.; Rayala, S.K.; Venkatraman, G.; Rangaswamy, R.; Jeyaraman, J. WaterMap and Molecular Dynamic Simulation-Guided Discovery of Potential PAK1 Inhibitors Using Repurposing Approaches. ACS Omega 2021, 6, 26829–26845. [Google Scholar] [CrossRef]
  56. Sobhia, M.E.; Ghosh, K.; Sivangula, S.; Kumar, S.; Singh, H. Identification of Potential SARS-CoV-2 Mpro Inhibitors Integrating Molecular Docking and Water Thermodynamics. J. Biomol. Struct. Dyn. 2022, 40, 5079–5089. [Google Scholar] [CrossRef]
  57. Schrödinger Release 2024-1: Desmond Molecular Dynamics System; D.E. Shaw Research: New York, NY, USA, 2024.
  58. Bowers, K.J.; Chow, E.; Xu, H.; Dror, R.O.; Eastwood, M.P.; Gregersen, B.A.; Klepeis, J.L.; Kolossvary, I.; Moraes, M.A.; Sacerdoti, F.D.; et al. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. In Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, SC’06, Tampa, FL, USA, 11–17 November 2006. [Google Scholar] [CrossRef]
  59. Iqbal, D.; Rehman, M.T.; Alajmi, M.F.; Alsaweed, M.; Jamal, Q.M.S.; Alasiry, S.M.; Albaker, A.B.; Hamed, M.; Kamal, M.; Albadrani, H.M. Multitargeted Virtual Screening and Molecular Simulation of Natural Product-like Compounds against GSK3β, NMDA-Receptor, and BACE-1 for the Management of Alzheimer’s Disease. Pharmaceuticals 2023, 16, 622. [Google Scholar] [CrossRef]
  60. Lieberman, H.B.; Hopkins, K.M.; Nass, M.; Demetrick, D.; Davey, S. A Human Homolog of the Schizosaccharomyces Pombe Rad9 Checkpoint Control Gene. Genetics 1996, 93, 13890–13895. [Google Scholar] [CrossRef]
  61. Lieberman, H.B. Rad9, an Evolutionarily Conserved Gene with Multiple Functions for Preserving Genomic Integrity. J. Cell Biochem. 2006, 97, 690–697. [Google Scholar] [CrossRef]
  62. Zhu, Y.; Xie, M.; Meng, Z.; Leung, L.K.; Chan, F.L.; Hu, X.; Chi, K.; Liu, C.; Yao, X. Knockdown of TM9SF4 Boosts ER Stress to Trigger Cell Death of Chemoresistant Breast Cancer Cells. Oncogene 2019, 38, 5778–5791. [Google Scholar] [CrossRef]
  63. Sun, J.; Ren, D. IER3IP1 Deficiency Leads to Increased β-Cell Death and Decreased β-Cell Proliferation. Oncotarget 2017, 8, 56768–56779. [Google Scholar] [CrossRef]
  64. Lounis, M.A.; Lalonde, S.; Rial, S.A.; Bergeron, K.F.; Ralston, J.C.; Mutch, D.M.; Mounier, C. Hepatic BSCL2 (Seipin) Deficiency Disrupts Lipid Droplet Homeostasis and Increases Lipid Metabolism via SCD1 Activity. Lipids 2017, 52, 129–150. [Google Scholar] [CrossRef]
  65. Rallis, C.; Townsend, S.; Bähler, J. Genetic Interactions and Functional Analyses of the Fission Yeast Gsk3 and Amk2 Single and Double Mutants Defective in TORC1-Dependent Processes. Sci. Rep. 2017, 7, srep44257. [Google Scholar] [CrossRef]
  66. Roguev, A.; Bandyopadhyay, S.; Zofall, M.; Zhang, K.; Fischer, T.; Collins, S.R.; Qu, H.; Shales, M.; Park, H.-O.; Hayles, J.; et al. Conservation and Rewiring of Functional Modules Revealed by an Epistasis Map in Fission Yeast. Science 2008, 322, 405–410. [Google Scholar] [CrossRef]
  67. VanderSluis, B.; Costanzo, M.; Billmann, M.; Ward, H.N.; Myers, C.L.; Andrews, B.J.; Boone, C. Integrating Genetic and Protein–Protein Interaction Networks Maps a Functional Wiring Diagram of a Cell. Curr. Opin. Microbiol. 2018, 45, 170–179. [Google Scholar] [CrossRef]
  68. Bouhaddou, M.; Eckhardt, M.; Chi Naing, Z.Z.; Kim, M.; Ideker, T.; Krogan, N.J. Mapping the Protein–Protein and Genetic Interactions of Cancer to Guide Precision Medicine. Curr. Opin. Genet. Dev. 2019, 54, 110–117. [Google Scholar] [CrossRef]
  69. Leclerc, G.M.; Leclerc, G.J.; Kuznetsov, J.N.; DeSalvo, J.; Barredo, J.C. Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts. PLoS ONE 2013, 8, e74420. [Google Scholar] [CrossRef]
  70. Meares, G.P.; Mines, M.A.; Beurel, E.; Eom, T.Y.; Song, L.; Zmijewska, A.A.; Jope, R.S. Glycogen Synthase Kinase-3 Regulates Endoplasmic Reticulum (ER) Stress-Induced CHOP Expression in Neuronal Cells. Exp. Cell Res. 2011, 317, 1621–1628. [Google Scholar] [CrossRef]
  71. Corazzari, M.; Gagliardi, M.; Fimia, G.M.; Piacentini, M. Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate. Front. Oncol. 2017, 7, 78. [Google Scholar] [CrossRef]
  72. Lustoza, A.C.D.M.; Palma, L.M.; Façanha, A.R.; Okorokov, L.A.; Okorokova-Façanha, A.L. P 5a-Type ATPase Cta4p Is Essential for Ca 2+ Transport in the Endoplasmic Reticulum of Schizosaccharomyces Pombe. PLoS ONE 2011, 6, e27843. [Google Scholar] [CrossRef]
  73. Schönthal, A.H. Endoplasmic Reticulum Stress: Its Role in Disease and Novel Prospects for Therapy. Scientifica 2012, 2012, 857516. [Google Scholar] [CrossRef]
  74. Chevrier, B.; D’Orchymont, H.; Schalk, C.; Tarnus, C.; Moras, D. The Structure of the Aeromonas Proteolytica Aminopeptidase Complexed with a Hydroxamate Inhibitor: Involvement in Catalysis of Glu151 and Two Zinc Ions of the Co-Catalytic Unit. Eur. J. Biochem. 1996, 237, 393–398. [Google Scholar] [CrossRef]
  75. Rawlings, N.D.; Barrett, A.J.; Thomas, P.D.; Huang, X.; Bateman, A.; Finn, R.D. The MEROPS Database of Proteolytic Enzymes, Their Substrates and Inhibitors in 2017 and a Comparison with Peptidases in the PANTHER Database. Nucleic Acids Res 2018, 46, D624–D632. [Google Scholar] [CrossRef]
  76. Auld, D.S. Catalytic Mechanisms for Metallopeptidases. In Handbook of Proteolytic Enzymes; Elsevier: Amsterdam, The Netherlands, 2013; Volume 1, pp. 370–396. [Google Scholar] [CrossRef]
  77. Hornbeck, P.V.; Zhang, B.; Murray, B.; Kornhauser, J.M.; Latham, V.; Skrzypek, E. PhosphoSitePlus, 2014: Mutations, PTMs and Recalibrations. Nucleic Acids Res 2015, 43, D512–D520. [Google Scholar] [CrossRef]
  78. Tsai, C.-F.; Wang, Y.-T.; Yen, H.-Y.; Tsou, C.-C.; Ku, W.-C.; Lin, P.-Y.; Chen, H.-Y.; Nesvizhskii, A.I.; Ishihama, Y.; Chen, Y.-J. Large-Scale Determination of Absolute Phosphorylation Stoichiometries in Human Cells by Motif-Targeting Quantitative Proteomics. Nat. Commun. 2015, 6, 6622. [Google Scholar] [CrossRef]
  79. Mancinelli, R.; Carpino, G.; Petrungaro, S.; Mammola, C.L.; Tomaipitinca, L.; Filippini, A.; Facchiano, A.; Ziparo, E.; Giampietri, C. Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases. Oxidative Med. Cell Longev. 2017, 2017, 4629495. [Google Scholar] [CrossRef]
  80. Plyte, S.E.; Feoktistova, A.; Burke, J.D.; Woodgett, J.R.; Gould, K.L. Schizosaccharomyces Pombe Skp1 Encodes a Protein Kinase Related to Mammalian Glycogen Synthase Kinase 3 and Complements a Cdc14 Cytokinesis Mutant. Mol. Cell Biol. 1996, 16, 179–191. [Google Scholar] [CrossRef]
  81. Kim, W.; Bennett, E.J.; Huttlin, E.L.; Guo, A.; Li, J.; Possemato, A.; Sowa, M.E.; Rad, R.; Rush, J.; Comb, M.J.; et al. Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome. Mol. Cell 2011, 44, 325–340. [Google Scholar] [CrossRef]
  82. Lumpkin, R.J.; Gu, H.; Zhu, Y.; Leonard, M.; Ahmad, A.S.; Clauser, K.R.; Meyer, J.G.; Bennett, E.J.; Komives, E.A. Site-Specific Identification and Quantitation of Endogenous SUMO Modifications under Native Conditions. Nat. Commun. 2017, 8, 1171. [Google Scholar] [CrossRef]
  83. Jumper, J.; Evans, R.; Pritzel, A.; Green, T.; Figurnov, M.; Ronneberger, O.; Tunyasuvunakool, K.; Bates, R.; Žídek, A.; Potapenko, A.; et al. Highly Accurate Protein Structure Prediction with AlphaFold. Nature 2021, 596, 583–589. [Google Scholar] [CrossRef]
  84. Laskowski, R.A.; Furnham, N.; Thornton, J.M. The Ramachandran Plot and Protein Structure Validation. In Biomolecular Forms and Functions; World Scientific Pub Co. Inc.: Hackensack, NJ, USA, 2013; pp. 62–75. [Google Scholar] [CrossRef]
  85. Holz, R.C. The Aminopeptidase from Aeromonas Proteolytica: Structure and Mechanism of Co-Catalytic Metal Centers Involved in Peptide Hydrolysis. Coord. Chem. Rev. 2002, 232, 5–26. [Google Scholar] [CrossRef]
  86. Desmarais, W.; Bienvenue, D.L.; Bzymek, K.P.; Petsko, G.A.; Ringe, D.; Holz, R.C. The High-Resolution Structures of the Neutral and the Low PH Crystals of Aminopeptidase from Aeromonas Proteolytica. J. Biol. Inorg. Chem. 2006, 11, 398–408. [Google Scholar] [CrossRef]
  87. Richards, A.L.; Eckhardt, M.; Krogan, N.J. Mass Spectrometry-based Protein–Protein Interaction Networks for the Study of Human Diseases. Mol. Syst. Biol. 2021, 17, e8792. [Google Scholar] [CrossRef]
  88. Hiller, O.; Lichte, A.; Oberpichler, A.; Kocourek, A.; Tschesche, H. Matrix Metalloproteinases Collagenase-2, Macrophage Elastase, Collagenase-3, and Membrane Type 1-Matrix Metalloproteinase Impair Clotting by Degradation of Fibrinogen and Factor XII. J. Biol. Chem. 2000, 275, 33008–33013. [Google Scholar] [CrossRef]
  89. Yasuhara, T.; Nakai, T.; Ohashi, A. Aminopeptidase Y, a New Aminopeptidase from Saccharomyces Cerevisiae. Purification, Properties, Localization, and Processing by Protease B. J. Biol. Chem. 1994, 269, 13644–13650. [Google Scholar] [CrossRef]
  90. Shiba, T.; Koga, H.; Shin, H.-W.; Kawasaki, M.; Kato, R.; Nakayama, K.; Wakatsuki, S. Structural Basis for Rab11-Dependent Membrane Recruitment of a Family of Rab11-Interacting Protein 3 (FIP3) Arfophilin-1. Proc. Natl. Acad. Sci. USA 2006, 103, 15416–15421. [Google Scholar] [CrossRef]
  91. Kumar, P.; Wolberger, C. Structure of the Yeast Bre1 RING Domain. Proteins Struct. Funct. Bioinform. 2015, 83, 1185–1190. [Google Scholar] [CrossRef]
  92. Wu, J.; Wang, Y.; Gan, J.; Wang, W.; Sun, B.; Huang, Z.X.; Xia, Z.X. Structures of Cytochrome B5 Mutated at the Charged Surface-Residues and Their Interactions with Cytochrome c. Chin. J. Chem. 2002, 2, 1225–1234. [Google Scholar] [CrossRef]
  93. Dohm, J.A.; Lee, S.J.; Hardwick, J.M.; Hill, R.B.; Gittis, A.G. Cytosolic Domain of the Human Mitochondrial Fission Protein Fis1 Adopts a TPR Fold. Proteins Struct. Funct. Genet. 2004, 54, 153–156. [Google Scholar] [CrossRef]
  94. Zhang, Y.; Inoue, M.; Tsutsumi, A.; Watanabe, S.; Nishizawa, T.; Nagata, K.; Kikkawa, M.; Inaba, K. Cryo-EM Structures of SERCA2b Reveal the Mechanism of Regulation by the Luminal Extension Tail. Sci. Adv. 2020, 6, eabb0147. [Google Scholar] [CrossRef]
  95. Kazanov, M.D.; Igarashi, Y.; Eroshkin, A.M.; Cieplak, P.; Ratnikov, B.; Zhang, Y.; Li, Z.; Godzik, A.; Osterman, A.L.; Smith, J.W. Structural Determinants of Limited Proteolysis. J. Proteome Res. 2011, 10, 3642–3651. [Google Scholar] [CrossRef]
  96. Oldfield, C.J.; Dunker, A.K. Intrinsically Disordered Proteins and Intrinsically Disordered Protein Regions. Annu. Rev. Biochem. 2014, 83, 553–584. [Google Scholar] [CrossRef]
  97. Ruff, K.M.; Pappu, R.V. AlphaFold and Implications for Intrinsically Disordered Proteins. J. Mol. Biol. 2021, 433, 167208. [Google Scholar] [CrossRef]
  98. Mahrus, S.; Trinidad, J.C.; Barkan, D.T.; Sali, A.; Burlingame, A.L.; Wells, J.A. Global Sequencing of Proteolytic Cleavage Sites in Apoptosis by Specific Labeling of Protein N Termini. Cell 2008, 134, 866–876. [Google Scholar] [CrossRef]
  99. Timmer, J.C.; Zhu, W.; Pop, C.; Regan, T.; Snipas, S.J.; Eroshkin, A.M.; Riedl, S.J.; Salvesen, G.S. Structural and Kinetic Determinants of Protease Substrates. Nat. Struct. Mol. Biol. 2009, 16, 1101–1108. [Google Scholar] [CrossRef]
  100. Hartmann, M.; Clark, T.; Van Eldik, R. Hydration and Water Exchange of Zinc (II) Ions. Application of Density Functional Theory. J. Am. Chem. Soc. 1997, 119, 7843–7850. [Google Scholar] [CrossRef]
  101. Zhao, M.; Wang, H.B.; Ji, L.N.; Mao, Z.W. Insights into Metalloenzyme Microenvironments: Biomimetic Metal Complexes with a Functional Second Coordination Sphere. Chem. Soc. Rev. 2013, 42, 8360–8375. [Google Scholar] [CrossRef]
  102. Zastrow, M.L.; Pecoraro, V.L. Designing Hydrolytic Zinc Metalloenzymes. Biochemistry 2014, 53, 957–978. [Google Scholar] [CrossRef]
  103. Jeong, W.J.; Lee, J.; Eom, H.; Song, W.J. A Specific Guide for Metalloenzyme Designers: Introduction and Evolution of Metal-Coordination Spheres Embedded in Protein Environments. Acc. Chem. Res. 2023, 56, 2416–2425. [Google Scholar] [CrossRef]
  104. Hitzerd, S.M.; Verbrugge, S.E.; Ossenkoppele, G.; Jansen, G.; Peters, G.J. Positioning of Aminopeptidase Inhibitors in next Generation Cancer Therapy. Amino Acids 2014, 46, 793–808. [Google Scholar] [CrossRef]
  105. Holstein, S.A.; Heckman, C.A.; Davies, F.E.; Morgan, G.J.; Gelius, S.S.; Lehmann, F. Aminopeptidases in Cancer, Biology and Prospects for Pharmacological Intervention. Curr. Cancer Drug Targets 2022, 23, 25–46. [Google Scholar] [CrossRef]
  106. Polaina, J.; MacCabe, A.P. Industrial Enzymes: Structure, Function and Applications; Springer: Berlin/Heidelberg, Germany, 2007; Chapter 15; pp. 243–260. ISBN 9781402053771. [Google Scholar]
  107. Mina-Osorio, P. The Moonlighting Enzyme CD13: Old and New Functions to Target. Trends Mol. Med. 2008, 14, 361–371. [Google Scholar] [CrossRef]
  108. Moore, H.E.; Davenport, E.L.; Smith, E.M.; Muralikrishnan, S.; Dunlop, A.S.; Walker, B.A.; Krige, D.; Drummond, A.H.; Hooftman, L.; Morgan, G.J.; et al. Aminopeptidase Inhibition as a Targeted Treatment Strategy in Myeloma. Mol. Cancer Ther. 2009, 8, 762–770. [Google Scholar] [CrossRef]
  109. Qi, L.; Tsai, B.; Arvan, P. New Insights into the Physiological Role of Endoplasmic Reticulum-Associated Degradation. Trends Cell Biol. 2017, 27, 430–440. [Google Scholar] [CrossRef]
  110. Suzuki, T.; Bridges, D.; Nakada, D.; Skiniotis, G.; Morrison, S.J.; Lin, J.D.; Saltiel, A.R.; Inoki, K. Inhibition of AMPK Catabolic Action by GSK3. Mol. Cell 2013, 50, 407–419. [Google Scholar]
  111. Xiao, B.; Sanders, M.J.; Carmena, D.; Bright, N.J.; Haire, L.F.; Underwood, E.; Patel, B.R.; Heath, R.B.; Walker, P.A.; Hallen, S.; et al. Structural Basis of AMPK Regulation by Small Molecule Activators. Nat. Commun. 2013, 4, 3017. [Google Scholar] [CrossRef]
  112. Cetrullo, S.; D’Adamo, S.; Tantini, B.; Borzì, R.M.; Flamigni, F. MTOR, AMPK, and Sirt1: Key Players in Metabolic Stress Management. Crit. Rev. Eukaryot. Gene Expr. 2015, 25, 59–75. [Google Scholar] [CrossRef]
  113. Evangelisti, C.; Chiarini, F.; Paganelli, F.; Marmiroli, S.; Martelli, A.M. Crosstalks of GSK3 Signaling with the MTOR Network and Effects on Targeted Therapy of Cancer. Biochim. Biophys. Acta Mol. Cell Res. 2020, 1867, 118635. [Google Scholar] [CrossRef]
  114. Nie, T.; Yang, S.; Ma, H.; Zhang, L.; Lu, F.; Tao, K.; Wang, R.; Yang, R.; Huang, L.; Mao, Z.; et al. Regulation of ER Stress-Induced Autophagy by GSK3Β-TIP60-ULK1 Pathway. Cell Death Dis. 2016, 7, e2563. [Google Scholar] [CrossRef]
  115. Liu, C.M.; Yang, H.X.; Ma, J.Q.; Yang, W.; Feng, Z.J.; Sun, J.M.; Cheng, C.; Li, J.; Jiang, H. Role of AMPK Pathway in Lead-Induced Endoplasmic Reticulum Stress in Kidney and in Paeonol-Induced Protection in Mice. Food Chem. Toxicol. 2018, 122, 87–94. [Google Scholar] [CrossRef]
  116. Nascimento Mello, A.L.; Sagrillo, F.S.; de Souza, A.G.; Costa, A.R.P.; Campos, V.R.; Cunha, A.C.; Imbroisi Filho, R.; da Costa Santos Boechat, F.; Sola-Penna, M.; de Souza, M.C.B.V.; et al. Selective AMPK Activator Leads to Unfolded Protein Response Downregulation and Induces Breast Cancer Cell Death and Autophagy. Life Sci. 2021, 276, 119470. [Google Scholar] [CrossRef]
  117. Hartmuth, S.; Petersen, J. Fission Yeast Tor1 Functions as Part of TORC1 to Control Mitotic Entry through the Stress MAPK Pathway Following Nutrient Stress. J. Cell Sci. 2009, 122, 1737–1746. [Google Scholar] [CrossRef]
  118. Wu, H.; Ng, B.S.H.; Thibault, G. Endoplasmic Reticulum Stress Response in Yeast and Humans. Biosci. Rep. 2014, 34, 321–330. [Google Scholar] [CrossRef]
  119. Hu, W.; Ohue, M. SpatialPPI: Three-Dimensional Space Protein-Protein Interaction Prediction with AlphaFold Multimer. Comput. Struct. Biotechnol. J. 2024, 23, 1214–1225. [Google Scholar] [CrossRef]
  120. Malladi, S.; Powell, H.R.; David, A.; Islam, S.A.; Copeland, M.M.; Kundrotas, P.J.; Sternberg, M.J.E.; Vakser, I.A. GWYRE: A Resource for Mapping Variants onto Experimental and Modeled Structures of Human Protein Complexes. J. Mol. Biol. 2022, 434, 167608. [Google Scholar] [CrossRef]
  121. Mishra, M.; Jiang, H.; Wei, Q. New Insights on the Differential Interaction of Sulfiredoxin with Members of the Peroxiredoxin Family Revealed by Protein-Protein Docking and Experimental Studies. Eur. J. Pharmacol. 2023, 954, 175873. [Google Scholar] [CrossRef]
  122. Jakhmola, V.; Parashar, T.; Ghildiyal, P.; Ansori, A.N.M.; Sharma, R.K.; Rao, N.G.R.; Kalra, K.; Singh, N.; Nainwal, N.; Singh, R.K.; et al. An In Silico Study to Explore the Role of EGFR in Ovarian Cancer. Pharmacogn. J. 2022, 14, 817–821. [Google Scholar] [CrossRef]
  123. Desta, I.T.; Porter, K.A.; Xia, B.; Kozakov, D.; Vajda, S. Performance and Its Limits in Rigid Body Protein-Protein Docking. Structure 2020, 28, 1071–1081. [Google Scholar] [CrossRef]
  124. Gupta, S.; Ali, A.; Pandey, S.; Khan, I.A.; Prakash, P. Fibronectin Containing Alternatively Spliced Extra Domain A Interacts at the Central and C-Terminal Domain of Toll-like Receptor-4. Sci. Rep. 2022, 12, 9662. [Google Scholar] [CrossRef]
  125. Sotudian, S.; Desta, I.T.; Hashemi, N.; Zarbafian, S.; Kozakov, D.; Vakili, P.; Vajda, S.; Paschalidis, I.C. Improved Cluster Ranking in Protein–Protein Docking Using a Regression Approach. Comput. Struct. Biotechnol. J. 2021, 19, 2269–2278. [Google Scholar] [CrossRef]
Figure 1. PPI network for human ERMP1. Information obtained from the BioGRID database. The network was edited using Cytoscape 3.10 software.
Figure 1. PPI network for human ERMP1. Information obtained from the BioGRID database. The network was edited using Cytoscape 3.10 software.
Cimb 46 00280 g001
Figure 2. Prediction of a PPI network for Ermp1 in S. pombe. The network was edited using Cytoscape 3.10 software.
Figure 2. Prediction of a PPI network for Ermp1 in S. pombe. The network was edited using Cytoscape 3.10 software.
Cimb 46 00280 g002
Figure 3. Clustering of Ermp1-interacting proteins in S. pombe: (A) Go cellular component and (B) biological process annotation.
Figure 3. Clustering of Ermp1-interacting proteins in S. pombe: (A) Go cellular component and (B) biological process annotation.
Cimb 46 00280 g003
Figure 4. Sequence alignment of the M28 domain of Ermp1 in humans and S. pombe.
Figure 4. Sequence alignment of the M28 domain of Ermp1 in humans and S. pombe.
Cimb 46 00280 g004
Figure 5. Three-dimensional structure of the M28 domain of Ermp1 from S. pombe. (A) Homology modeling in Phyre2. Binding site Zn2+ shown in orange. (B) Model validation using the PROCHECK-SAVES v6.0 server. Ramachandran plot shows 85.4% residues are in the most favored region. Editing of the model performed in UCSF Chimera 1.17.1.
Figure 5. Three-dimensional structure of the M28 domain of Ermp1 from S. pombe. (A) Homology modeling in Phyre2. Binding site Zn2+ shown in orange. (B) Model validation using the PROCHECK-SAVES v6.0 server. Ramachandran plot shows 85.4% residues are in the most favored region. Editing of the model performed in UCSF Chimera 1.17.1.
Cimb 46 00280 g005
Figure 6. Representation of the catalytic cavity of the M28 domain of Ermp1 from S. pombe. (A) Surface model and (B) residues comprising the catalytic cavity. The gray dots represent the coordination bonds between residues with Zn2+. Editing of the model performed in Maestro 13.0.
Figure 6. Representation of the catalytic cavity of the M28 domain of Ermp1 from S. pombe. (A) Surface model and (B) residues comprising the catalytic cavity. The gray dots represent the coordination bonds between residues with Zn2+. Editing of the model performed in Maestro 13.0.
Cimb 46 00280 g006
Figure 7. Molecular docking of the M28 domain of Ermp1 with protein targets (AF). Highlighted are the binding sites for Zn2+ in orange, the catalytic site in purple, and the catalytic stabilizer in magenta. Additionally, the predicted phosphorylation sites are indicated in cyan. The hydrophobic areas are indicated by the yellow sites, and the ligand cleavage site is represented by the blue segment. The cleavage points are indicated by the pink residues. Solvation was performed using the WaterMap tool, and the models were edited in Maestro 13.0.
Figure 7. Molecular docking of the M28 domain of Ermp1 with protein targets (AF). Highlighted are the binding sites for Zn2+ in orange, the catalytic site in purple, and the catalytic stabilizer in magenta. Additionally, the predicted phosphorylation sites are indicated in cyan. The hydrophobic areas are indicated by the yellow sites, and the ligand cleavage site is represented by the blue segment. The cleavage points are indicated by the pink residues. Solvation was performed using the WaterMap tool, and the models were edited in Maestro 13.0.
Cimb 46 00280 g007
Figure 8. Molecular dynamics simulation. Variation in the root mean square deviation (RMSD) of the Ermp1–Pex12, Ermp1–Amk2 and Ermp1–Ypt5 complexes. Each simulation was 120 ns long in the Desmond Molecular Dynamics System to assess the stability of the protein–protein interactions.
Figure 8. Molecular dynamics simulation. Variation in the root mean square deviation (RMSD) of the Ermp1–Pex12, Ermp1–Amk2 and Ermp1–Ypt5 complexes. Each simulation was 120 ns long in the Desmond Molecular Dynamics System to assess the stability of the protein–protein interactions.
Cimb 46 00280 g008
Table 1. Prediction of PROSPER cleavage sites of Ermp1 target proteins in S. pombe.
Table 1. Prediction of PROSPER cleavage sites of Ermp1 target proteins in S. pombe.
Human ProteinUniProt IDOrtholog SCHPO 1UniProt IDMMP 2 PredictionSegmentPositionScore 3
PRKAB1Q9Y478Amk2P78789MMP9RAQS Cimb 46 00280 i001 MISIMet401.16
RAB5CP51148Ypt5P36586MMP9SLAP Cimb 46 00280 i001 MYYRMet831.08
PEX12O00623Pex12Q8TFH8MMP9FWRL Cimb 46 00280 i001 MIMet3421.22
CYB5BO43169Oca8Q9USM6MMP9GEEV Cimb 46 00280 i001 LVDLLeu450.98
FIS1Q9Y3D6Fis1Q9USZ8MMP9EALK Cimb 46 00280 i001 LKNRLeu1171.05
ATP2B2Q01814Pmc1Q9HDW7MMP9TTMA Cimb 46 00280 i001 MRTEMet4291.23
1 Schizosaccharomyces pombe. 2 Metalloproteinase. 3 Values greater than 0.8 increase the confidence of predicting proteolytic cleavage. Cimb 46 00280 i001 Cleavage site.
Table 2. Homology modeling in Phyre2 of Ermp1 target proteins in S. pombe. Model validation performed using PDBeFold and PROCHECK-SAVES v6.0.
Table 2. Homology modeling in Phyre2 of Ermp1 target proteins in S. pombe. Model validation performed using PDBeFold and PROCHECK-SAVES v6.0.
ProteinTemplateOrganismPDB IDIdentity PercentageQ-Score 1RMSD 2 (Å)Ramachandran Plot 3
Ypt5Rab11H. sapiens2D7C [90]43%0.950.3387.1%
Pex12Ring 3 ligaseS. cerevisiae4R7E [91]28%0.710.7185.1%
Oca8Cytochrome b5B. taurus1M2I [92]50%1.000.0090.3%
Fis1Fis1H. sapiens1NZN [93]25%0.900.4990.0%
Pmc1SERCA2bH. sapiens6LLE [94]28%0.800.4787.5%
1 Q-score: quality of alignment, the highest score = 1. 2 RMSD: the lower the RMSD, the better the model is in comparison to the target structure. 3 Ramachandran plot: a good quality model would be expected to find more than 85–90% in the most favored regions.
Table 3. Prediction of cleavage sites by docking of target proteins and Ermp1 in S. pombe. Comparison of molecular-docking results in ClusPro and BioLuminate.
Table 3. Prediction of cleavage sites by docking of target proteins and Ermp1 in S. pombe. Comparison of molecular-docking results in ClusPro and BioLuminate.
Ligand
SCHPO 1
Docking
Prediction
Docking
Program
PIPER Energy ScoreCluster Size
Amk2RAQS Cimb 46 00280 i001 MISIClusPro
BioLuminate
−923.2
−951.3
28
57
Ypt5S Cimb 46 00280 i001 LAPMYYRClusPro
BioLuminate
−645.5
−638.4
31
28
Pex12FWR Cimb 46 00280 i001 LMIClusPro
BioLuminate
−680.8
−667.4
124
78
Oca8GEEVLVD Cimb 46 00280 i001 LClusPro
BioLuminate
−500.6
−542.6
62
54
Fis1EALKLKN Cimb 46 00280 i001 RClusPro
BioLuminate
−607.1
−633.0
92
74
Pmc1TT Cimb 46 00280 i001 MAMRTEClusPro
BioLuminate
−1137.7
−1212.5
35
20
1 Schizosaccharomyces pombeCimb 46 00280 i001 Cleavage site.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

González-Esparragoza, D.; Carrasco-Carballo, A.; Rosas-Murrieta, N.H.; Millán-Pérez Peña, L.; Luna, F.; Herrera-Camacho, I. In Silico Analysis of Protein–Protein Interactions of Putative Endoplasmic Reticulum Metallopeptidase 1 in Schizosaccharomyces pombe. Curr. Issues Mol. Biol. 2024, 46, 4609-4629. https://doi.org/10.3390/cimb46050280

AMA Style

González-Esparragoza D, Carrasco-Carballo A, Rosas-Murrieta NH, Millán-Pérez Peña L, Luna F, Herrera-Camacho I. In Silico Analysis of Protein–Protein Interactions of Putative Endoplasmic Reticulum Metallopeptidase 1 in Schizosaccharomyces pombe. Current Issues in Molecular Biology. 2024; 46(5):4609-4629. https://doi.org/10.3390/cimb46050280

Chicago/Turabian Style

González-Esparragoza, Dalia, Alan Carrasco-Carballo, Nora H. Rosas-Murrieta, Lourdes Millán-Pérez Peña, Felix Luna, and Irma Herrera-Camacho. 2024. "In Silico Analysis of Protein–Protein Interactions of Putative Endoplasmic Reticulum Metallopeptidase 1 in Schizosaccharomyces pombe" Current Issues in Molecular Biology 46, no. 5: 4609-4629. https://doi.org/10.3390/cimb46050280

APA Style

González-Esparragoza, D., Carrasco-Carballo, A., Rosas-Murrieta, N. H., Millán-Pérez Peña, L., Luna, F., & Herrera-Camacho, I. (2024). In Silico Analysis of Protein–Protein Interactions of Putative Endoplasmic Reticulum Metallopeptidase 1 in Schizosaccharomyces pombe. Current Issues in Molecular Biology, 46(5), 4609-4629. https://doi.org/10.3390/cimb46050280

Article Metrics

Back to TopTop